A multicenter observational study on the efficacy and tolerability of Privigen® (intravenous immunoglobulin preparation) - Interim analysis with focus on immune thrombocytopenia (ITP)

被引：0
|
作者：
Tschechne, B.
Otremba, B.
Lotichius, P. [1 ]
Pfruender, D. [1 ]
机构：
[1] CSL Behring, Hattersheim, Germany
来源：
ONKOLOGIE | 2011年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：170 / 171
页数：2
相关论文
共 46 条
  • [1] A Multicenter Non-Interventional Study On The Efficacy and Tolerability Of The Polyvalent Intravenous Immunoglobulin Privigen®
    Hoffmann, Rainer
    Lotichius, Peer
    Pfruender, Dietmar
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB183 - AB183
  • [2] Efficacy and Tolerability of the Polyvalent Intravenous Immunoglobulin (IVIG) Privigen® - A Multicenter Non-Interventional Study
    Hoffmann, R.
    Lotichius, P.
    Pfruender, D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB141 - AB141
  • [3] Efficacy and Tolerability of Privigen in Secondary Immunodeficiencies - Results from a Multicenter Observational Study
    Slawik, H. R.
    Plath, M.
    Reiser, M.
    Otremba, B.
    Lotichius, P.
    Pfruender, D.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S296 - S296
  • [4] Efficacy and tolerability of Privigen® (IgPro10) in primary and secondary immunodeficiencies - A multicenter observational study
    Otremba, B.
    Slawik, H. R.
    Tschechne, B.
    Lotichius, P.
    Pfruender, D.
    PROCEEDINGS OF THE 15TH MEETING OF THE EUROPEAN SOCIETY IMMUNODEFICIENCIES (ESID), 2013, : 15 - 18
  • [5] EFFICACY AND TOLERABILITY OF PRIVIGEN® (IGPRO10) IN PRIMARY AND SECONDARY IMMUNODEFICIENCIES - A MULTICENTER OBSERVATIONAL STUDY
    Otremba, B.
    Slawik, H. R.
    Tschechne, B.
    Lotichius, P.
    Pfruender, D.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 158 - 159
  • [6] Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP)
    Hong, Junshik
    Bang, Soo-Mee
    Mun, Yeung-Chul
    Yhim, Ho-Young
    Lee, Jaehoon
    Lim, Hyeong-Seok
    Oh, Doyeun
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (19)
  • [7] Corticosteroids Plus Intravenous Immunoglobulin Compared with Corticosteroids for the Treatment of Immune Thrombocytopenia in Pregnancy: An Observational Multicenter Study in China
    Zhu, Xiao-Lu
    Wang, Jing-Wen
    Shen, Jian-Liang
    Liu, Hui
    Feng, Ru
    Yin, Cheng-Hong
    Chang, Ying-Jun
    Qian, Jiang
    Jiang, Hao
    Lu, Jin
    Liang, Mei-Ying
    Zhang, Xiao-Hong
    Wang, Jian-Liu
    Xu, Lan-Ping
    Liu, Kai-Yan
    Huang, Xiao-Jun
    Zhang, Xiao-Hui
    BLOOD, 2017, 130
  • [8] Therapy of patients with chronic immune thrombocytopenic purpura (ITP): Efficacy, tolerability, and safety of a new nanoflltered intravenous immunoglobulin
    Wolf, HH
    Davies, S
    Smith, G
    Sklenar, I
    Adams, C
    Andresen, I
    7TH ANNUAL MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION, 2002, : 389 - 395
  • [9] Interim results of a multicentre, non-interventional study (NIS) on the tolerability and efficacy of octagam® 5% and octagam® 10% in patients with immune thrombocytopenia (ITP)
    Dengler, J.
    Debes, A.
    U., Muenster
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 91 - 91
  • [10] A multicenter observational study on the efficacy and tolerability of Privigen® in patients with chronic lymphocytic leukaemia (CLL), hypogammaglobulinemia and recurrent bacterial infections
    Otremba, B.
    Lotichius, P.
    Pfruender, D.
    ONKOLOGIE, 2013, 36 : 57 - 58
12345